Back to spin-outs

OncoMargin

Entered program in 2024

OncoMargin aim to bring certainty to breast cancer surgery, by reducing the number of recurrent operations.

Back to spin-outs
Magnus Jensen University of Southern Denmark (SDU)
Oncology
Raman
Biotech

At OncoMargin we aim to revolutionise surgical precision with our proprietary Raman Spectral Projection Tomography (RPT)—a state‐of‐the‐art 3D chemical imaging system delivering real-time, non-destructive tissue analysis. Enabling precise tumour margin assessment, RPT reduces repeat surgeries and enhances patient outcomes. Our solution integrates seamlessly into surgical workflows to support optimal intraoperative decision-making.

Photo: Robert Wagner

Magnus Jensen

Dr. Magnus Jensen is a Postdoctoral Researcher and entrepreneur at SDU, specialising in biomedical. His innovation contributions have earned him multiple awards, underscoring his commitment to excellence in research and development. Dr. Jensen is currently leading efforts to assemble a team to launch a cutting-edge spinout venture.

LinkedIn

This project is supported by Spin-outs Denmark, a unique program that invests in researchers who create more impact by starting research-based companies.

Learn more about the program
Discover other spin-outs in the program